Eric Ng, SCMP News

Eric Ng

SCMP News

Hong Kong

Contact Eric

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Unknown
Past:
  • SCMP News

Past articles by Eric:

China’s aim to integrate Greater Bay Area comes together with Hong Kong health care providers playing a leading role

Health care is a vital part of Beijing’s goal to make the Greater Bay Area liveable for migrants. The inclusion of Hong Kong-based providers in the mainland’s insurance network is likely to spur cross-border flow of talent. → Read More

China’s Big Tech companies are using their roles in fighting world’s largest health crisis to turbocharge HealthTech

In the second of a five-part series on China’s health care system, Eric Ng looks at how technological innovations – smartphone applications, 5G, big data, artificial intelligence – are coming together to help in the battle with the country’s worst public health crisis in two decades. → Read More

Coronavirus forces postponement of business start-ups festival in Hong Kong, health care conference in Shanghai

The coronavirus epidemic has forced more business events to be postponed, including a major annual start-up promotion initiative in Hong Kong. → Read More

China coronavirus sends health care, e-commerce stocks soaring, while travel and retail firms take a hammering

The rapid spread of the Wuhan coronavirus that has seen transport services and business events cancelled, and kept consumers at home in cities across China has battered travel and retail stocks. But it is proving a boon for health care, home entertainment and e-commerce shares. → Read More

Hong Kong listed firms get ‘F’ on ESG report card, put on notice as rules become mandatory in 2021

Hong Kong-listed companies are giving the city a bad name by failing the “comply or explain” test on environmental disclosure. They have been put on notice as compliance on social issues becomes mandatory from 2021. → Read More

Convoy scandal continues as Hong Kong firm seeks damages from Ernst & Young for 2013 audit

Convoy Global Holdings, the centre of one of Hong Kong’s biggest financial scandals in the past decade, is suing its former auditor Ernst & Young for alleged breach of duty or negligence during its audit and advisory work six years ago. → Read More

Beijing’s latest policy shows strongest resolve yet to enlist private firms to enhance national energy security

Beijing’s directive this week to support private companies by levelling the playing field with their state-owned rivals and breaking their stranglehold in the energy sector is the strongest example yet of its resolve to mobilise entrepreneurs to help stem China’s record-high reliance on foreign oil and gas. → Read More

Can cheaper drugs help home-grown labs turn the table on foreign Big Pharma in China’s cancer treatment market?

A war is being waged in China’s market for cancer drugs, where home-grown laboratories must strike a delicate balance between social responsibility and cash flow in a long-term strategy to occupy the lion’s share of sales of immuno-oncology treatments. → Read More

New EU scrutiny mechanism to cool Chinese acquisition of strategic assets in Europe, says ING

Chinese appetite for assets in sectors such as energy and power utilities will be affected by the passage last week of an EU-wide mechanism for the screening of foreign investment into strategic sectors, said Hu Jia, head of Greater China corporate finance at ING. → Read More

Encourage Hong Kong employees to raise voluntary MPF contributions with tax incentives, says advisory body

Employees contributing to Hong Kong’s Mandatory Provident Fund should be given tax incentives to encourage them to increase their contributions, according to a report released by the Financial Services Development Council on Thursday. This will help plug the gap between contributions and retirement needs.... → Read More

Russian gas exports will spark ‘explosive’ growth in underserved northeast, says China’s largest distributor

China’s underserved northeast will record “explosive” growth in consumption when Russian gas finally arrives next year in the region, the country’s only area not serviced by a natural gas trunk pipeline.... → Read More

Tariff hikes won’t affect US, which is poised for longest period of economic growth since 1785, says Indosuez economist

If they do go up, levies will be rising from record low level, says Marie Owens Thomsen, global head of investment intelligence at Indosuez Wealth Management, the private banking arm of Credit Agricole Group → Read More

Will trimmed subsidy roll back knock the wind out of Taiwan’s offshore turbine sector?

A retrospective reduction in subsidies for offshore wind power development by Taiwan could take the wind out of international developers’ sails, and erode some of the sector’s attractiveness relative to Japan, mainland China and South Korea as an investment destination.... → Read More

A successful US-China trade deal would boost copper, aluminium prices, analysts say

The recent rebound in prices of several key industrial metals will continue this year – and would get an added boost by a successful US-China trade deal, analysts say.... → Read More

Will China lose its tech mojo as venture capital for start-ups gets harder to come by?

With money going to later-stage tech giants, can the ‘red unicorn’ wave keep rolling on? → Read More

Rare boardroom spat draws spotlight on corporate governance at Hong Kong-listed company

Shares of China Traditional Chinese Medicine Holdings plunged on Monday after an independent non-executive director resigned, accusing the company of governance shortcomings, including a lack of transparency and improper approval processes for director pay.... → Read More

Meet Wuxi Biologics, the contract drugs maker that believes it can help cure China’s scandal-hit vaccine market

Wuxi Biologics, China’s largest biologic drugs services company, is in talks to sign contracts for the development of three potential vaccinations, in a bid to grab a slice of the nation’s scandal-hit market. ... → Read More

China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs

China’s pharmaceutical industry – shaken by drastic price cuts from Beijing’s recent pilot roll-out of state hospital bulk purchase open bidding – will need to go through painful restructuring and raise big sums to fund innovation, according to executives.... → Read More

Hong Kong highlights its role as a green bond hub for mainland firms

Hong Kong and mainland Chinese finance regulators have joined forces to promote the city as a green finance hub, inviting dozens of mainland companies to explore the benefits of fundraising with a view to ethical and social benefits.... → Read More

Can premature ejaculation spray rescue the sagging fortune of this Hong Kong firm and improve the sex lives of Asian men?

Regent Pacific Group, a Hong Kong-listed company that transformed itself three times over three decades, said it had secured regulatory approvals and a licence to sell a spray for treating premature ejaculation in Hong Kong and Macau, and not a moment too soon.... → Read More